DK3194407T3 - Makrocykliske RIP2-kinaseinhibitorer - Google Patents
Makrocykliske RIP2-kinaseinhibitorer Download PDFInfo
- Publication number
- DK3194407T3 DK3194407T3 DK15766800.5T DK15766800T DK3194407T3 DK 3194407 T3 DK3194407 T3 DK 3194407T3 DK 15766800 T DK15766800 T DK 15766800T DK 3194407 T3 DK3194407 T3 DK 3194407T3
- Authority
- DK
- Denmark
- Prior art keywords
- kinase inhibitors
- rip2 kinase
- macrocyclic
- macrocyclic rip2
- inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/529—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim forming part of bridged ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14185130 | 2014-09-17 | ||
PCT/EP2015/071347 WO2016042087A1 (en) | 2014-09-17 | 2015-09-17 | Macrocyclic rip2 kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3194407T3 true DK3194407T3 (da) | 2020-01-27 |
Family
ID=51687776
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK15766800.5T DK3194407T3 (da) | 2014-09-17 | 2015-09-17 | Makrocykliske RIP2-kinaseinhibitorer |
Country Status (26)
Country | Link |
---|---|
US (1) | US10676486B2 (da) |
EP (1) | EP3194407B1 (da) |
JP (1) | JP6736545B2 (da) |
KR (1) | KR102563829B1 (da) |
CN (1) | CN106687464B (da) |
AU (1) | AU2015316799B2 (da) |
BR (1) | BR112017004035B1 (da) |
CA (1) | CA2958782C (da) |
DK (1) | DK3194407T3 (da) |
EA (1) | EA032872B1 (da) |
ES (1) | ES2763344T3 (da) |
HR (1) | HRP20192334T1 (da) |
HU (1) | HUE048518T2 (da) |
IL (1) | IL250544B (da) |
LT (1) | LT3194407T (da) |
MX (1) | MX2017003469A (da) |
MY (1) | MY186523A (da) |
PL (1) | PL3194407T3 (da) |
PT (1) | PT3194407T (da) |
SA (1) | SA517381087B1 (da) |
SG (1) | SG11201701116XA (da) |
SI (1) | SI3194407T1 (da) |
TW (1) | TWI709563B (da) |
UA (1) | UA121315C2 (da) |
WO (1) | WO2016042087A1 (da) |
ZA (1) | ZA201701331B (da) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180088113A (ko) * | 2017-01-26 | 2018-08-03 | 한미약품 주식회사 | 이미다조피리다진 화합물 |
CN115698020A (zh) * | 2020-01-31 | 2023-02-03 | 昂科迪塞恩精密医药公司(Opm) | 大环rip2-激酶抑制剂 |
CN117659043A (zh) * | 2022-09-07 | 2024-03-08 | 苏州朗睿生物医药有限公司 | 一种大环咪唑并[1,2-b]哒嗪衍生物及其制备方法和用途 |
WO2024146541A1 (en) * | 2023-01-03 | 2024-07-11 | Guangdong Newopp Biopharmaceuticals Co., Ltd. | Macrocyclic compounds as usp1 inhibitors |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IS2334B (is) | 1992-09-08 | 2008-02-15 | Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) | Aspartyl próteasi hemjari af nýjum flokki súlfonamíða |
DE69429357T2 (de) | 1993-10-01 | 2002-08-14 | Astrazeneca Ab, Soedertaelje | Verfahren i |
US6043358A (en) | 1995-11-01 | 2000-03-28 | Merck & Co., Inc. | Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
GB9718913D0 (en) | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Substituted oxindole derivatives |
US6369087B1 (en) | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
WO2008058126A2 (en) * | 2006-11-06 | 2008-05-15 | Supergen, Inc. | Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors |
AR077468A1 (es) * | 2009-07-09 | 2011-08-31 | Array Biopharma Inc | Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa |
KR101852169B1 (ko) * | 2010-05-20 | 2018-04-26 | 어레이 바이오파마 인크. | Trk 키나제 저해제로서의 매크로시클릭 화합물 |
WO2013001310A1 (en) * | 2011-06-30 | 2013-01-03 | Centro Nacional De Investigaciones Oncológicas (Cnio) | Macrocyclic compounds and their use as cdk8 inhibitors |
TWI547494B (zh) * | 2011-08-18 | 2016-09-01 | 葛蘭素史克智慧財產發展有限公司 | 作為激酶抑制劑之胺基喹唑啉類 |
MX342177B (es) | 2011-09-30 | 2016-09-20 | Ipsen Pharma Sas | Inhibidores de cinasa 2 de repeticion rica en leucina (lrrk2) macrociclica. |
CN103930427B (zh) * | 2011-09-30 | 2016-03-09 | 昂科迪塞恩股份有限公司 | 大环flt3激酶抑制剂 |
-
2015
- 2015-09-17 SG SG11201701116XA patent/SG11201701116XA/en unknown
- 2015-09-17 UA UAA201703558A patent/UA121315C2/uk unknown
- 2015-09-17 CA CA2958782A patent/CA2958782C/en active Active
- 2015-09-17 EP EP15766800.5A patent/EP3194407B1/en active Active
- 2015-09-17 MY MYPI2017700447A patent/MY186523A/en unknown
- 2015-09-17 KR KR1020177010128A patent/KR102563829B1/ko active IP Right Grant
- 2015-09-17 US US15/505,976 patent/US10676486B2/en active Active
- 2015-09-17 PL PL15766800T patent/PL3194407T3/pl unknown
- 2015-09-17 DK DK15766800.5T patent/DK3194407T3/da active
- 2015-09-17 AU AU2015316799A patent/AU2015316799B2/en active Active
- 2015-09-17 JP JP2017514486A patent/JP6736545B2/ja active Active
- 2015-09-17 ES ES15766800T patent/ES2763344T3/es active Active
- 2015-09-17 MX MX2017003469A patent/MX2017003469A/es active IP Right Grant
- 2015-09-17 SI SI201531050T patent/SI3194407T1/sl unknown
- 2015-09-17 LT LTEP15766800.5T patent/LT3194407T/lt unknown
- 2015-09-17 EA EA201790609A patent/EA032872B1/ru unknown
- 2015-09-17 CN CN201580050163.3A patent/CN106687464B/zh active Active
- 2015-09-17 BR BR112017004035-2A patent/BR112017004035B1/pt active IP Right Grant
- 2015-09-17 PT PT157668005T patent/PT3194407T/pt unknown
- 2015-09-17 HU HUE15766800A patent/HUE048518T2/hu unknown
- 2015-09-17 TW TW104130751A patent/TWI709563B/zh active
- 2015-09-17 WO PCT/EP2015/071347 patent/WO2016042087A1/en active Application Filing
-
2017
- 2017-02-09 IL IL250544A patent/IL250544B/en active IP Right Grant
- 2017-02-22 ZA ZA2017/01331A patent/ZA201701331B/en unknown
- 2017-03-14 SA SA517381087A patent/SA517381087B1/ar unknown
-
2019
- 2019-12-27 HR HRP20192334TT patent/HRP20192334T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2016002502A1 (es) | Inhibidores de biaril cinasa | |
DK3442972T3 (da) | Bromdomænehæmmere | |
PL3218378T3 (pl) | Pochodne 6-amino-7-bicyklo-7-deazapuryny jako inhibitory kinaz białkowych | |
DK3119772T3 (da) | Heteroaryl syk-hæmmere | |
BR112017000042A2 (pt) | inibidores de desmetilase-1 lisina-específica | |
DK3191487T3 (da) | Spirocykliske cathepsin-c-inhibitorer | |
DK3125898T3 (da) | Farmakofor til trail-induktion | |
DK3102778T3 (da) | Fræseindretning | |
DK3186242T3 (da) | Alfa-amino-beta-carboxymuconsyre-semialdehyd-decarboxylasehæmmere | |
DK3114120T3 (da) | Tetrazolon-substituerede dihydropyridinon-mgat2-hæmmere | |
DK3341379T3 (da) | EZH2-hæmmere | |
DK3231803T3 (da) | Dihydroindolizinonderivat | |
DK3131898T3 (da) | Fluoroalkylfluorenderivativer | |
DK3191466T3 (da) | Azetidinyloxyphenylpyrrolidinforbindelser | |
DE112014006148A5 (de) | Schubladenausziehführung | |
ZA201701331B (en) | Macrocyclic rip2 kinase inhibitors | |
DE112015003475A5 (de) | Spannfutter | |
MA44607A (fr) | Inhibiteurs de kinase | |
DE112015002884A5 (de) | Schublade | |
DK3481826T3 (da) | Tyrosinkinaseinhibitorer | |
DK3436047T3 (da) | Duale Ace-C-Domain-inhibitorer | |
BR112016027901A2 (pt) | Compostos | |
FR3024538B1 (fr) | Extensometre radial | |
FI20145287A (fi) | Kaappisänky | |
TH1501006103A (th) | สารยับยั้งโปรตีนไคเนส |